Close

Process Considerations for Cryogenic and Regenerative Medicine Commercialization

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

A New Era of Pharmaceutical Documentation

There’s a dynamic duo transforming the face of the...

New back pain clinical trial

PharmaLinea's >Your< Back Pain Capsules clinically shown to substantially...

Made Smarter and tech institutes join forces to demystify digital transformation

‘Made Smarter technologies: powering the digital transformation of SME...

Why Tissue Paper Is The Smart Choice For A Sustainable World

COMMITTED TO SUSTAINABILITY ACROSS THE SUPPLY CHAIN ETS is committed...

McKesson, Fisher BioServices, GE Healthcare and Cryoport are proud to announce our first annual workshop. Our FREE two-day workshop will provide a forum for industry experts to present and discuss current technological advancements in cryogenic management, regulatory requirements and best practices for processes in the support of regenerative medicine commercialization.

The event is aimed at biotechnology and pharmaceutical professionals who want to learn more about the critical considerations for the development and commercialization of these vital therapies.

 

To download the complete White Paper click here

Latest stories